Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay

BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitar...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of endocrinology Vol. 166; no. 4; pp. 613 - 618
Main Authors Deutschbein, Timo, Broecker-Preuss, Martina, Flitsch, Jörg, Jaeger, Andrea, Althoff, Ricarda, Walz, Martin K, Mann, Klaus, Petersenn, Stephan
Format Journal Article
LanguageEnglish
Published Bristol BioScientifica 01.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h. ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.ResultsWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.ConclusionsThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.
AbstractList BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h. ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.ResultsWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.ConclusionsThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.
Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA). Unstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA. When screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h. The newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.
Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).BACKGROUNDSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).Unstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.METHODSUnstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.When screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.RESULTSWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.The newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.CONCLUSIONSThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.
Author Mann, Klaus
Jaeger, Andrea
Deutschbein, Timo
Althoff, Ricarda
Walz, Martin K
Petersenn, Stephan
Broecker-Preuss, Martina
Flitsch, Jörg
Author_xml – sequence: 1
  givenname: Timo
  surname: Deutschbein
  fullname: Deutschbein, Timo
– sequence: 2
  givenname: Martina
  surname: Broecker-Preuss
  fullname: Broecker-Preuss, Martina
– sequence: 3
  givenname: Jörg
  surname: Flitsch
  fullname: Flitsch, Jörg
– sequence: 4
  givenname: Andrea
  surname: Jaeger
  fullname: Jaeger, Andrea
– sequence: 5
  givenname: Ricarda
  surname: Althoff
  fullname: Althoff, Ricarda
– sequence: 6
  givenname: Martin K
  surname: Walz
  fullname: Walz, Martin K
– sequence: 7
  givenname: Klaus
  surname: Mann
  fullname: Mann, Klaus
– sequence: 8
  givenname: Stephan
  surname: Petersenn
  fullname: Petersenn, Stephan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25826709$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22214924$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rFTEYhYNU7G115V6ykS7KaJLJzE3cyeXWDwou7MJdeCcfNTKT1LwzhfkF_m1z6S2CiIuQEJ5z3uScM3KScvKEvOTsDe9a9nb_ed9w3jAtuydkw-VWN71qv52QDVNMNrKX7Sk5Q_zBGK9n9oycCiG41EJuyK-vMMZ7KCu1ucwR80gBKVAX4TZlnKOlc66XIRe6W_B7TLcXSHFNruTJU0iOgis-wUhjwiWEaKNPdn1H43RX8r13FG3xPlUhHdYqoLDMeYKDc5ymJWVAhPU5eRpgRP_iuJ-Tm6v9ze5jc_3lw6fd--tmkH07N0IJ5axmrXVeD7rzQyeCU9Ix2wnhO666unwvrJBBtIMKVoce2mCHQbtte04uHmzr234uHmczRbR-HCH5vKDRfVsnqE5V8tWRXIbJO3NX4lRjMo_RVeD1EQC0MIYCyUb8w3VK9FumK8cfOFsyYvHB2DjX7-c0F4ij4cwcajS1RsO5OdRYNZd_aR5t_00fJwwx4yH-OdYa4L-a33GzsA4
CitedBy_id crossref_primary_10_1186_1472_6823_14_75
crossref_primary_10_1111_cen_13490
crossref_primary_10_1515_cclm_2023_0141
crossref_primary_10_1007_s13631_016_0135_5
crossref_primary_10_1016_j_biopsycho_2024_108892
crossref_primary_10_1007_s13631_016_0113_y
crossref_primary_10_1177_0004563218824622
crossref_primary_10_1254_fpj_141_302
crossref_primary_10_3803_EnM_2020_707
crossref_primary_10_1210_clinem_dgaa105
crossref_primary_10_1007_s40292_016_0153_4
crossref_primary_10_1186_s40798_020_00269_4
crossref_primary_10_1097_MED_0000000000000331
crossref_primary_10_1530_EJE_12_0685
crossref_primary_10_3343_alm_2020_40_4_285
crossref_primary_10_1016_j_jad_2012_12_002
crossref_primary_10_1186_s40413_016_0117_0
crossref_primary_10_1016_j_beem_2021_101519
crossref_primary_10_1186_s13098_019_0481_3
crossref_primary_10_1097_MED_0000000000000806
crossref_primary_10_1530_EJE_13_0159
crossref_primary_10_1016_j_ijcard_2015_10_084
crossref_primary_10_1530_EC_18_0085
crossref_primary_10_1007_s13631_015_0088_0
crossref_primary_10_1515_jpem_2017_0270
crossref_primary_10_1007_s12020_013_0129_2
crossref_primary_10_2147_JPR_S252278
crossref_primary_10_4158_EP171887_OR
crossref_primary_10_3389_fendo_2022_1075785
crossref_primary_10_1007_s12020_014_0378_8
crossref_primary_10_1210_clinem_dgad763
crossref_primary_10_3390_diagnostics11040728
crossref_primary_10_3390_biomedicines8090314
crossref_primary_10_1007_s11102_012_0397_5
crossref_primary_10_1007_s12020_020_02392_4
crossref_primary_10_1177_0004563216687335
crossref_primary_10_1530_EJE_13_0702
crossref_primary_10_1002_alr_21228
crossref_primary_10_1136_jim_2018_000752
crossref_primary_10_1111_cen_14286
crossref_primary_10_1007_s11154_013_9240_1
crossref_primary_10_1007_s11102_022_01249_5
crossref_primary_10_1007_s13631_015_0078_2
crossref_primary_10_1111_cen_14920
crossref_primary_10_5507_bp_2024_033
crossref_primary_10_1007_s12020_013_0013_0
crossref_primary_10_1016_j_psyneuen_2015_08_016
crossref_primary_10_1186_s13063_016_1347_8
crossref_primary_10_3390_jcm9103233
crossref_primary_10_1210_jc_2019_00304
crossref_primary_10_1016_j_beem_2013_05_015
crossref_primary_10_2174_1573396315666191026100643
crossref_primary_10_1007_s12020_016_0978_6
crossref_primary_10_1016_j_job_2014_06_001
crossref_primary_10_1016_j_ando_2023_10_007
crossref_primary_10_1007_s00761_017_0319_2
crossref_primary_10_1080_07420528_2021_2016796
crossref_primary_10_1007_s40292_018_0288_6
crossref_primary_10_1007_s11102_015_0639_4
crossref_primary_10_1530_EC_18_0257
crossref_primary_10_1155_2019_7251010
crossref_primary_10_1007_s40618_018_0921_1
crossref_primary_10_1210_js_2016_1056
Cites_doi 10.1111/j.1365-2265.2005.02421.x
10.1016/j.cca.2009.11.033
10.1373/49.8.1408
10.1210/jc.2004-2264
10.1373/clinchem.2008.108910
10.1210/jc.2006-1791
10.1210/jc.2008-0139
10.1515/CCLM.2006.244
10.1093/clinchem/43.8.1386
10.1258/acb.2008.008208
10.1210/jc.84.3.878
10.7326/0003-4819-139-3-200308050-00017
10.1016/S0140-6736(03)13492-7
10.1210/jc.2009-1166
10.1093/clinchem/48.1.207
10.1530/EJE-08-0600
10.1530/EJE-09-0517
10.1530/eje.0.1340093
10.1111/j.1365-2265.2008.03381.x
10.1210/jc.2002-021897
10.1055/s-0029-1225630
10.1210/jc.2010-0982
10.1210/jc.2008-0125
10.1258/acb.2007.007119
10.1210/jc.2002-020534
ContentType Journal Article
Copyright 2012 European Society of Endocrinology
2015 INIST-CNRS
Copyright_xml – notice: 2012 European Society of Endocrinology
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1530/EJE-11-0945
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Assay-specific salivary cortisol reference values
EISSN 1479-683X
EndPage 618
ExternalDocumentID 22214924
25826709
10_1530_EJE_11_0945
Genre Controlled Clinical Trial
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
169
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
5WD
AABZA
AACZT
AAPGJ
AAPXW
AAVAP
AAWDT
ABLYK
ABOCM
ABPQP
ABPTD
ABPTK
ABSGY
ABSQV
ABWST
ABXZS
ACFRR
ACGFO
ACNCT
ACPRK
ACUTJ
ADBBV
ADDZX
ADIPN
ADQBN
ADVEK
AENEX
AEQTP
AFFNX
AFGWE
AFHIN
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALXQX
ANFBD
APJGH
BAWUL
BCRHZ
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F9R
GX1
HZ~
IL9
INIJC
J5H
KOP
KQ8
L7B
O9-
OAUYM
OBFPC
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
RHF
ROX
SJN
TBS
TCN
TEORI
TMA
TR2
VH1
W8F
WOQ
X7M
ZA5
ZGI
ZXP
AARHZ
AAUAY
AAYXX
ABDFA
ABEJV
ABGNP
ABIME
ABJNI
ABMNT
ABNHQ
ABPIB
ABQNK
ABVGC
ABXVV
ADGKP
ADMTO
ADNBA
ADVOB
AEMQT
AFXAL
AGORE
AHGBF
AHMMS
AJBYB
AJNCP
ATGXG
CITATION
H13
IQODW
NU-
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-b463t-2828dc903cde9b95eb52fd84d0c522e5185518e62c24f23b8fc9f6a3fcbb9d73
ISSN 0804-4643
1479-683X
IngestDate Thu Jul 10 17:36:42 EDT 2025
Thu Apr 03 07:01:50 EDT 2025
Mon Jul 21 09:14:45 EDT 2025
Tue Jul 01 04:13:21 EDT 2025
Thu Apr 24 22:57:18 EDT 2025
Sun Jan 07 07:18:52 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Endocrinopathy
Corticosteroid
Adrenal cortex diseases
Steroid hormone
Antiinflammatory agent
Cushing syndrome
Hyperadrenocorticism
Cortisol
Medical screening
Hydrocortisone
Glucocorticoid
Immunological method
Adrenal insufficiency
Adrenal hormone
Adrenal gland diseases
Diagnosis
Saliva
Endocrinology
Tool
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b463t-2828dc903cde9b95eb52fd84d0c522e5185518e62c24f23b8fc9f6a3fcbb9d73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink http://dx.doi.org/10.1530/EJE-11-0945
PMID 22214924
PQID 963828858
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_963828858
pubmed_primary_22214924
pascalfrancis_primary_25826709
crossref_citationtrail_10_1530_EJE_11_0945
crossref_primary_10_1530_EJE_11_0945
bioscientifica_primary_10_1530_EJE_11_0945
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-04-01
PublicationDateYYYYMMDD 2012-04-01
PublicationDate_xml – month: 04
  year: 2012
  text: 2012-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Bristol
PublicationPlace_xml – name: Bristol
– name: England
PublicationTitle European journal of endocrinology
PublicationTitleAlternate Eur J Endocrinol
PublicationYear 2012
Publisher BioScientifica
Publisher_xml – name: BioScientifica
References Dorin (17_17752659) 2003; 139
(20_37934287) 2010; 95
(10_35518615) 2009; 161
Cardoso (16_31746579) 2009; 70
(23_23549960) 2007; 92
Schmidt (18_17809027) 2003; 88
Vogeser (11_23126745) 2006; 44
(6_31793921) 2008; 54
Deutschbein (9_35255002) 2009; 41
van Aken (26_17737107) 2003; 49
Beko (12_36156278) 2010; 411
(8_35272673) 2009; 94
(15_19452889) 2005; 90
Raff (21_11451575) 2002; 48
(19_32342951) 2009; 160
(3_30600398) 2008; 93
(4_30600400) 2008; 93
Papanicolaou (22_17269627) 2002; 87
Arlt (1_17660455) 2003; 361
(7_33708272) 2009; 46
(5_32894395) 2006; 27
Castro (14_10754938) 1999; 84
Reynolds (2_21386388) 2006; 64
Barrou (13_16173049) 1996; 134
Wood (25_31334434) 2008; 45
Turpeinen (24_5708013) 1997; 43
References_xml – volume: 64
  start-page: 82
  issn: 0300-0664
  issue: 1
  year: 2006
  ident: 2_21386388
  publication-title: Clinical endocrinology
  doi: 10.1111/j.1365-2265.2005.02421.x
– volume: 411
  start-page: 364
  issn: 1873-3492
  issue: 5-6
  year: 2010
  ident: 12_36156278
  publication-title: Clinica Chimica Acta
  doi: 10.1016/j.cca.2009.11.033
– volume: 49
  start-page: 1408
  issn: 0009-9147
  issue: 8
  year: 2003
  ident: 26_17737107
  publication-title: Clinical Chemistry
  doi: 10.1373/49.8.1408
– volume: 90
  start-page: 5730
  issn: 0021-972X
  issue: 10
  year: 2005
  ident: 15_19452889
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2004-2264
– volume: 54
  start-page: 1759
  issn: 0009-9147
  issue: 11
  year: 2008
  ident: 6_31793921
  publication-title: Clinical Chemistry
  doi: 10.1373/clinchem.2008.108910
– volume: 92
  start-page: 1326
  issn: 0021-972X
  issue: 4
  year: 2007
  ident: 23_23549960
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2006-1791
– volume: 93
  start-page: 1553
  issn: 0021-972X
  issue: 5
  year: 2008
  ident: 4_30600400
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2008-0139
– volume: 44
  start-page: 1441
  issn: 1434-6621
  issue: 12
  year: 2006
  ident: 11_23126745
  publication-title: Clinical chemistry and laboratory medicine : CCLM / FESCC
  doi: 10.1515/CCLM.2006.244
– volume: 43
  start-page: 1386
  issn: 0009-9147
  issue: 8
  year: 1997
  ident: 24_5708013
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/43.8.1386
– volume: 46
  start-page: 183
  issn: 0004-5632
  issue: 3
  year: 2009
  ident: 7_33708272
  publication-title: Annals of Clinical Biochemistry
  doi: 10.1258/acb.2008.008208
– volume: 84
  start-page: 878
  issn: 0021-972X
  issue: 3
  year: 1999
  ident: 14_10754938
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.84.3.878
– volume: 139
  start-page: 194
  issn: 0003-4819
  issue: 3
  year: 2003
  ident: 17_17752659
  publication-title: Annals of Internal Medicine
  doi: 10.7326/0003-4819-139-3-200308050-00017
– volume: 361
  start-page: 1881
  issn: 0140-6736
  issue: 9372
  year: 2003
  ident: 1_17660455
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13492-7
– volume: 94
  start-page: 3647
  issn: 0021-972X
  issue: 10
  year: 2009
  ident: 8_35272673
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2009-1166
– volume: 48
  start-page: 207
  issn: 0009-9147
  issue: 1
  year: 2002
  ident: 21_11451575
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/48.1.207
– volume: 160
  start-page: 9
  issn: 0804-4643
  issue: 1
  year: 2009
  ident: 19_32342951
  publication-title: European Journal of Endocrinology
  doi: 10.1530/EJE-08-0600
– volume: 27
  start-page: 139
  year: 2006
  ident: 5_32894395
  publication-title: CLINICAL BIOCHEMIST REVIEWS
– volume: 161
  start-page: 747
  issn: 0804-4643
  issue: 5
  year: 2009
  ident: 10_35518615
  publication-title: European Journal of Endocrinology
  doi: 10.1530/EJE-09-0517
– volume: 134
  start-page: 93
  issn: 0804-4643
  issue: 1
  year: 1996
  ident: 13_16173049
  publication-title: European Journal of Endocrinology
  doi: 10.1530/eje.0.1340093
– volume: 70
  start-page: 516
  issn: 0300-0664
  issue: 4
  year: 2009
  ident: 16_31746579
  publication-title: Clinical endocrinology
  doi: 10.1111/j.1365-2265.2008.03381.x
– volume: 88
  start-page: 4193
  issn: 0021-972X
  issue: 9
  year: 2003
  ident: 18_17809027
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2002-021897
– volume: 41
  start-page: 834
  issn: 0018-5043
  issue: 11
  year: 2009
  ident: 9_35255002
  publication-title: Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et m  tabolisme
  doi: 10.1055/s-0029-1225630
– volume: 95
  start-page: 4855
  issn: 0021-972X
  issue: 11
  year: 2010
  ident: 20_37934287
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2010-0982
– volume: 93
  start-page: 1526
  issn: 0021-972X
  issue: 5
  year: 2008
  ident: 3_30600398
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2008-0125
– volume: 45
  start-page: 380
  issn: 0004-5632
  issue: 4
  year: 2008
  ident: 25_31334434
  publication-title: Annals of Clinical Biochemistry
  doi: 10.1258/acb.2007.007119
– volume: 87
  start-page: 4515
  issn: 0021-972X
  issue: 10
  year: 2002
  ident: 22_17269627
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2002-020534
SSID ssj0016430
Score 2.3049412
Snippet BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific...
Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges...
SourceID proquest
pubmed
pascalfrancis
crossref
bioscientifica
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 613
SubjectTerms Adrenal Insufficiency - diagnosis
Adrenal Insufficiency - metabolism
Adrenals. Adrenal axis. Renin-angiotensin system (diseases)
Adult
Automation
Biological and medical sciences
Clinical Study
Cushing Syndrome - diagnosis
Cushing Syndrome - metabolism
Diagnostic Techniques, Endocrine - instrumentation
Diagnostic Techniques, Endocrine - standards
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
High-Throughput Screening Assays - instrumentation
High-Throughput Screening Assays - methods
High-Throughput Screening Assays - standards
Humans
Hydrocortisone - analysis
Hydrocortisone - metabolism
Immunoassay - instrumentation
Immunoassay - methods
Immunoassay - standards
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
Prevention and actions
Public health. Hygiene
Public health. Hygiene-occupational medicine
Reference Values
ROC Curve
Saliva - chemistry
Saliva - metabolism
Sensitivity and Specificity
Vertebrates: endocrinology
Title Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay
URI http://dx.doi.org/10.1530/EJE-11-0945
https://www.ncbi.nlm.nih.gov/pubmed/22214924
https://www.proquest.com/docview/963828858
Volume 166
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9RAEF7OCqKoaOvL-VL2Q1GwpOY2u3uJ39p6UioVxRP6LewmGwnIpdwlH84_4E_xbzqzu7kkWMX64cIRdvPCPJmdmZ15hpA9WNVzJpgIwmLKA15I3CTMZWAijgxmJhN2R_fsgzz5wk_Pxflo9LOXtdTU-iD7fmldyf9IFc6BXLFK9gqS3VwUTsB_kC8cQcJw_CcZf1a4kbNc74MLWZdwL-waozCeiulzSMVaI8UmZhIeNzbWZMPzLUuBI2rFUm7LvLFqLJ0E1mJinKC04QawR0GxgLOLIQWNZE37qqkrR_RaYnFJBea3GmwODyL83to1i7wCBTWM4r81TQ3etfYNNxE3vfCAwYyP4OPSNK6xu2M8UB3iSpxsYYjb_UfSc3VZ5gDz1bfpxoRN1Y9tYJII78c2jsrKajibNaX6mhHGcen4nQ6M09x8mgQyts2FO9XuOrp4DPOeopaTqLfmS7cG_LaciAjzL2enM1t9mHBxjVxn4I9gq4z3n7rtKngUG8xrn8sXgsL0173Jt8gdXTqKUvdGA1vo9oVawWdZuH4qf3Z4rOEzv0fueo-FHjr43Scjs9gmO4cLBShY0xfU5hBbsW6TG2c-VWOH_GjBSVtwUrWiinbgpAhOCuCkHpwvV7SFJgVoUg9NOoDmG9oCk26ASfUaJtANMGkPmA_I_N1sfnwS-K4fgeYyqgOMAeRZEkZZbhKdCKMFK_KY52EGvoIRYGDCz0iWMV6wSMdFlhRSRUWmdZJPo4dka1EtzGNCjRFahGZqRDLhGVjmuSoiOLB8kpiwkGPyaiiP9MIxvKToGYPwUhAeuMgpCg8Gt7JKM0-fj11cvl0-eG8z-K_X3B0IfTOWCfD6p2EyJrRFQQpqH_fy1MJUzSrFdZPFsYjH5JFDRzeZsQlPGH9yldd7Sm52H-AzslUvG_MczO1a71qo_wKek9xt
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Salivary+cortisol+as+a+diagnostic+tool+for+Cushing%27s+syndrome+and+adrenal+insufficiency%3A+improved+screening+by+an+automatic+immunoassay&rft.jtitle=European+journal+of+endocrinology&rft.au=Deutschbein%2C+Timo&rft.au=Broecker-Preuss%2C+Martina&rft.au=Flitsch%2C+J%C3%B6rg&rft.au=Jaeger%2C+Andrea&rft.date=2012-04-01&rft.pub=BioScientifica&rft.issn=0804-4643&rft.eissn=1479-683X&rft.volume=166&rft.issue=4&rft.spage=613&rft.epage=618&rft_id=info:doi/10.1530%2FEJE-11-0945
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon